{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T01:45:10Z","timestamp":1776390310679,"version":"3.51.2"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T00:00:00Z","timestamp":1607472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Chronic granulomatous disease (CGD) is a primary immune deficiency due to defects in phagocyte respiratory burst leading to severe and life-threatening infections. Patients with CGD also suffer from disorders of inflammation and immune dysregulation including colitis and granulomatous lung disease, among others. Additionally, patients with CGD may be at increased risk of systemic inflammatory disorders such as hemophagocytic lymphohistiocytosis (HLH). The presentation of HLH often overlaps with symptoms of systemic inflammatory response syndrome (SIRS) or sepsis and therefore can be difficult to identify, especially in patients with a primary immune deficiency in which incidence of infection is increased. Thorough evaluation and empiric treatment for bacterial and fungal infections is necessary as HLH in CGD is almost always secondary to infection. Simultaneous treatment of infection with anti-microbials and inflammation with immunosuppression may be needed to blunt the hyperinflammatory response in secondary HLH. Herein, we present a series of X-linked CGD patients who developed HLH secondary to or with concurrent disseminated CGD-related infection. In two patients, CGD was a known diagnosis prior to development of HLH and in the other two CGD was diagnosed as part of the evaluation for HLH. Concurrent infection and HLH were fatal in three; one case was successfully treated, ultimately receiving hematopoietic stem cell transplantation. The current literature on presentation, diagnosis, and treatment of HLH in CGD is reviewed.<\/jats:p>","DOI":"10.3389\/fimmu.2020.581475","type":"journal-article","created":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T07:35:21Z","timestamp":1607499321000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Case Report: Secondary Hemophagocytic Lymphohistiocytosis With Disseminated Infection in Chronic Granulomatous Disease\u2014A Serious Cause of Mortality"],"prefix":"10.3389","volume":"11","author":[{"given":"Jacqueline D.","family":"Squire","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie N.","family":"Vazquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele E.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak","family":"Chellapandian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Vose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Teppa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. Celine","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan K.","family":"Chinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Forbes-Satter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filiz O.","family":"Seeborg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah K.","family":"Nicholas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caridad A.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl E.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J.","family":"Connors","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prakash","family":"Satwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Shtessel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanadys","family":"Ale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lenora M.","family":"Noroski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas L.","family":"Rider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua D.","family":"Milner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer W.","family":"Leiding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,12,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1093\/jpids\/piy014","article-title":"Noninfectious Manifestations and Complications of Chronic Granulomatous Disease","volume":"7","author":"Henrickson","year":"2018","journal-title":"J Pediatr Infect Dis Soc"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.121608","article-title":"The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesis","volume":"100","author":"Bode","year":"2015","journal-title":"Haematologica"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.22830","article-title":"Hemophagocytic lymphohistiocytosis in children with chronic granulomatous disease","volume":"56","author":"Parekh","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/01.PCC.0000149131.72248.E6","article-title":"International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics","volume":"6","author":"Goldstein","year":"2005","journal-title":"Pediatr Crit Care Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.critrevonc.2017.03.023","article-title":"Similar but not the same: Differential diagnosis of HLH and sepsis","volume":"114","author":"Machowicz","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2014-2175","article-title":"Chronic granulomatous disease presenting as hemophagocytic lymphohistiocytosis: a case report","volume":"134","author":"Valentine","year":"2014","journal-title":"Pediatrics"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/ped.13064","article-title":"Hemophagocytic lymphohistiocytosis: Pathogenesis, diagnosis, and management","volume":"58","author":"Morimoto","year":"2016","journal-title":"Pediatr Int"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2018.11.050","article-title":"Hemophagocytic Lymphohistiocytosis: Clinical Presentations and Diagnosis","volume":"7","author":"Risma","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31819c6f3a","article-title":"Visceral leishmaniasis associated hemophagocytic syndrome in patients with chronic granulomatous disease","volume":"28","author":"Martin","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.47071-0","article-title":"Bacteria-associated haemophagocytic syndrome and septic pulmonary embolism caused by Burkholderia cepacia complex in a woman with chronic granulomatous disease","volume":"56","author":"Hisano","year":"2007","journal-title":"J Med Microbiol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21851","article-title":"Fatal hemophagocytic lymphohistiocytosis in X-linked chronic granulomatous disease associated with a perforin gene variant","volume":"52","author":"van Montfrans","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000137565.23501.03","article-title":"Hemophagocytic syndrome and Burkholderia cepacia splenic microabscesses in a child with chronic granulomatous disease","volume":"23","author":"Sirinavin","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0b013e31828e5dae","article-title":"A case of macrophage activation syndrome developing in a patient with chronic granulomatous disease-associated colitis","volume":"36","author":"Akagi","year":"2014","journal-title":"J Pediatr Hematol Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2015.06.010","article-title":"Macrophage Activation Syndrome","volume":"29","author":"Ravelli","year":"2015","journal-title":"Hematol Oncol Clin North Am"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00119","article-title":"The Immunology of Macrophage Activation Syndrome","volume":"10","author":"Crayne","year":"2019","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1182\/blood-2017-11-814244","article-title":"Genetic and mechanistic diversity in pediatric hemophagocytic lymphohistiocytosis","volume":"132","author":"Chinn","year":"2018","journal-title":"Blood"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-011-9616-5","article-title":"Intravenous immunoglobulin treatment for macrophage activation syndrome complicating chronic granulomatous disease","volume":"32","author":"Alvarez-Cardona","year":"2012","journal-title":"J\u00a0Clin Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0000000000000302","article-title":"Treatment of hemophagocytic lymphohistiocytosis","volume":"24","author":"Wang","year":"2017","journal-title":"Curr Opin Hematol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1097\/PCC.0000000000000078","article-title":"Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis\/sepsis\/multiple organ dysfunction\/macrophage activating syndrome in critically ill children*","volume":"15","author":"Rajasekaran","year":"2014","journal-title":"Pediatr Crit Care Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24188","article-title":"Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab","volume":"60","author":"Marsh","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"B22","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2165\/00003495-199957020-00006","article-title":"Basiliximab","volume":"57","author":"Onrust","year":"1999","journal-title":"Drugs"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1911326","article-title":"Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis","volume":"382","author":"Locatelli","year":"2020","journal-title":"N Engl J Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019002289","article-title":"Emapalumab for the treatment of relapsed\/refractory hemophagocytic lymphohistiocytosis","volume":"134","author":"Vallurupalli","year":"2019","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1182\/bloodadvances.2018025858","article-title":"Treatment of refractory hemophagocytic lymphohistiocytosis with emapalumab despite severe concurrent infections","volume":"3","author":"Lounder","year":"2019","journal-title":"Blood Adv"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.11.030","article-title":"Hemophagocytic lymphohistiocytosis in 2 patients with underlying IFN-\u03b3 receptor deficiency","volume":"135","author":"Tesi","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2014.07.004","article-title":"Successful stem cell transplantation in a child with chronic granulomatous disease associated with contiguous gene deletion syndrome and complicated by macrophage activation syndrome","volume":"154","author":"Scheffler-Mendoza","year":"2014","journal-title":"Clin Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.581475\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T07:35:23Z","timestamp":1607499323000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.581475\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,9]]},"references-count":27,"alternative-id":["10.3389\/fimmu.2020.581475"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.581475","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,9]]},"article-number":"581475"}}